From Pretest to Clinical Decision: The Value of Risk Reclassification

Authors

DOI:

https://doi.org/10.52787/agl.v56i2.664

Keywords:

Pretest, risk reclassification

Abstract

In medicine, we are constantly seeking new diagnostic and prognostic tools. As a result, clinical variables, serum biomarkers, imaging techniques, and novel predictive models are continually being incorporated with the aim of improving risk assessment and guiding clinical decision-making for our patients. However, a mere statistical association between a variable and a clinical outcome does not guarantee its usefulness in clinical practice.

When a new marker emerges, its value lies not only in its ability to predict events, but also in whether it provides information capable of modifying a patient's risk estimation in a clinically meaningful way.1 In other words, does it enable better decision-making?

References

-1. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7):928-35.

-2. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1980;302(20):1109-17.

-3. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119(17):2408-16.

-4. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36.

-5. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39(4):561-77.

-6. Kerr KF, Wang Z, Janes H, McClelland RL, Psaty BM, Pepe MS. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology. 2014;25(1):114-21.

-7. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-72; discussion 207-12.

-8. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25).

Published

2026-06-30

How to Cite

Decotto, S., Miceli, A., & Pizarro, R. (2026). From Pretest to Clinical Decision: The Value of Risk Reclassification. Acta Gastroenterológica Latinoamericana, 56(2), 127–134. https://doi.org/10.52787/agl.v56i2.664